A pilot study comparing the role of positron-emission (PET) and computed tomography (CT) fusion scan (PET-CT) and contrast-enhanced magnetic resonance imaging (MRI) in the staging of locoregionally nasopharyngeal carcinoma (NPC)

Magnetic resonance imaging (MRI) has become an indispensable tool in the assessment of malignant disease. With increasingly sophisticated systems and technical advancements, MRI has continued to expand its role in providing crucial information regarding cancer diagnosis and management. In gynecological malignancies, this modality has assumed greater responsibility, particularly in the evaluation of cervical and endometrial cancers. In addition to conventional imaging, innovative techniques such as dynamic contrast-enhanced MRI and diffusion-weighted MRI show promise in offering early assessment of tumor response. This paper reviews the current role of MRI in gynecological cancers and highlights the potential of novel techniques in improving patient care.

Download Full-text

Imaging of larynx: Diagnostic value of computed tomography and magnetic resonance imaging

Acta chirurgica iugoslavica ◽

10.2298/aci0903039m ◽

2009 ◽

Vol 56 (3) ◽

pp. 39-44

Author(s):

R.M. Maksimovic ◽

B.A. Banko ◽

J.P. Milovanovic

Keyword(s):

Magnetic Resonance Imaging ◽

Computed Tomography ◽

Magnetic Resonance ◽

Regional Lymph Node ◽

Diagnostic Value ◽

Resonance Imaging ◽

Precise Diagnosis ◽

Node Metastases ◽

Magnetic Resonance Imaging Mri

Computed tomography (CT) and magnetic resonance imaging (MRI) are enabling more precise diagnosis and treatment planning in patients with diseases of the larynx. The aim of this article is to describe the role of these methods in assessment of the laringeal diseases and key local anatomic characteristics important for spread of the disease. CT and MRI have a valuable contribution to the staging of the tumors due to the possibility to show the relationship to the ventricular complex, involvement of the subumucosal spaces, defining craniocaudal and anterposterior extension, laringeal cartilage invasion, as well as regional lymph node metastases.

Download Full-text

The diagnostic role of ultrasonography, computed tomography, magnetic resonance imaging, positron emission tomography/computed tomography, and real-time elastography in the differentiation of benign and malignant salivary gland tumors: a meta-analysis

Oral Surgery Oral Medicine Oral Pathology and Oral Radiology ◽

10.1016/j.oooo.2019.06.014 ◽

2019 ◽

Vol 128 (4) ◽

pp. 431-443.e1 ◽

Cited By ~ 2

Author(s):

Xiangpan Kong ◽

Hua Li ◽

Zhengxue Han

Keyword(s):

Magnetic Resonance Imaging ◽

Computed Tomography ◽

Positron Emission Tomography ◽

Meta Analysis ◽

Emission Tomography ◽

Resonance Imaging ◽

Positron Emission ◽

Diagnostic Role ◽

Malignant Salivary Gland Tumors

Download Full-text

Prospective Evaluation of Magnetic Resonance Imaging and [18F]Fluorodeoxyglucose Positron Emission Tomography-Computed Tomography at Diagnosis and Before Maintenance Therapy in Symptomatic Patients With Multiple Myeloma Included in the IFM/DFCI 2009 Trial: Results of the IMAJEM Study

Journal of Clinical Oncology ◽

10.1200/jco.2017.72.2975 ◽

2017 ◽

Vol 35 (25) ◽

pp. 2911-2918 ◽

Cited By ~ 102

Author(s):

Philippe Moreau ◽

Michel Attal ◽

Denis Caillot ◽

Margaret Macro ◽

Lionel Karlin ◽

...

Keyword(s):

Magnetic Resonance Imaging ◽

Computed Tomography ◽

Positron Emission Tomography ◽

Multiple Myeloma ◽

Emission Tomography ◽

Bone Lesions ◽

Resonance Imaging ◽

Positron Emission ◽

Pet Ct ◽

Ct And Mri

Purpose Magnetic resonance imaging (MRI) and positron emission tomography–computed tomography (PET-CT) are important imaging techniques in multiple myeloma (MM). We conducted a prospective trial in patients with MM aimed at comparing MRI and PET-CT with respect to the detection of bone lesions at diagnosis and the prognostic value of the techniques. Patients and Methods One hundred thirty-four patients received a combination of lenalidomide, bortezomib, and dexamethasone (RVD) with or without autologous stem-cell transplantation, followed by lenalidomide maintenance. PET-CT and MRI were performed at diagnosis, after three cycles of RVD, and before maintenance therapy. The primary end point was the detection of bone lesions at diagnosis by MRI versus PET-CT. Secondary end points included the prognostic impact of MRI and PET-CT regarding progression-free (PFS) and overall survival (OS). Results At diagnosis, MRI results were positive in 127 of 134 patients (95%), and PET-CT results were positive in 122 of 134 patients (91%; P = .33). Normalization of MRI after three cycles of RVD and before maintenance was not predictive of PFS or OS. PET-CT became normal after three cycles of RVD in 32% of the patients with a positive evaluation at baseline, and PFS was improved in this group (30-month PFS, 78.7% v 56.8%, respectively). PET-CT normalization before maintenance was described in 62% of the patients who were positive at baseline. This was associated with better PFS and OS. Extramedullary disease at diagnosis was an independent prognostic factor for PFS and OS, whereas PET-CT normalization before maintenance was an independent prognostic factor for PFS. Conclusion There is no difference in the detection of bone lesions at diagnosis when comparing PET-CT and MRI. PET-CT is a powerful tool to evaluate the prognosis of de novo myeloma.

Download Full-text